Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
Healthy Volunteers
ID06638528

Effects of Walking Apnea At High Lung Volume on Hypoalgesia

Led by Universidad Rey Juan Carlos · Updated on 2024-10-15

60

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This trial investigates the effect of intermittent walking apnea at high lung volume on reducing pain sensitivity in healthy adults aged 18 to 64. Researchers also study how this training influences cardiovascular and respiratory responses during the exercise. The goal is to understand how a 6-minute session of walking with controlled breath-holding impacts pain perception and body functions. Participants are randomly assigned to one of two groups: the experimental group walks on a treadmill at 6 km/h with a 10% slope performing intermittent apneas—holding their breath for 5 seconds followed by normal breathing for 5 seconds—over 6 minutes. The control group walks at the same speed and slope but breathes normally throughout the 6-minute session. Both groups are monitored during the exercise. During the study, researchers measure pain pressure thresholds at specific body sites before and up to 30 minutes after the intervention. They also assess perceived stress, sleep quality, and physical activity before the session. Heart rate and oxygen levels are tracked during the walking, and perceived exertion is recorded immediately afterward. Participants will be observed for these responses to evaluate the effects of the walking apnea training compared to normal breathing.

CONDITIONS

Brief Title

Effects of Walking Apnea At High Lung Volume on Hypoalgesia

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Asymptomatic subjects aged between 18 and 64 years.
Not Eligible

You will not qualify if you...

  • Cardiovascular, respiratory, metabolic, neurological, or osteomuscular signs or pathologies.
  • History of epilepsy.
  • Pregnant.
  • Taking pharmacological treatment.
  • Present any type of pain on the day of the measurements or have frequently suffered pain during the previous 4 weeks.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 6 minutes

Participants walk on a treadmill at 6 km/h with a 10% slope for 6 minutes. Participants in the experimental group perform intermittent apneas at high lung volume during the walk, while the control group breathes normally.

1 treatment visit (in-person)

Follow-up

Duration - Up to 30 minutes after treatment

Participants undergo assessments of pain pressure threshold and rate of perceived exertion before and after the treatment visit, with monitoring of heart rate and oxygen saturation during the intervention.

1 follow-up visit (in-person)

Trial Site Locations

Total: 1 location

1

CSEU LaSalle

Madrid, Spain

Actively Recruiting

Loading map...

Research Team

F

Francisco De Asís Fernandez, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Combined Treatment of Manual Therapy and Nervous Vagus Sti...

Temporomandibular Joint Disorders

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here